Evidence map›Paper›PMID 35482483›Full record

ArticleHealth policy and planning2022

Advocacy organizations and nutrition policy in Nigeria: identifying metrics for enhanced efficacy.

Danielle Resnick, Kola Anigo, Olufolakemi Mercy Anjorin

Abstract read
In one paragraph

Article in Health policy and planning, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Danielle ResnickBrookings Institution, Global Economy and Development Program, 1775 Massachusetts Avenue NW, Washington, DC 20036, USA.ORCID 0000-0001-6285-3461
Kola AnigoAhmadu Bello University, Food and Nutrition Unit, Department of Biochemistry, Samaru Campus, Community Market, Zaria 810211, Nigeria.
Olufolakemi Mercy AnjorinUniversity of Ibadan, Department of Human Nutrition, Ward XI, Nw8, Ibadan, Nigeria.

Funding

Bill and Melinda Gates Foundation OPP1174256
6 · The paper itself

Abstract

Advocacy organizations have played a significant role in the field of nutrition in recent years. However, why are some advocates viewed as more effective than others? This paper derives metrics for assessing advocacy efficacy by first drawing on key insights from the nutrition and public policy scholarship. A set of metrics is proposed to capture the constitutive elements of three concepts that often emerge as critical from that literature: organizational capacity, strong networks and external outreach. Based on a survey of 66 nutrition stakeholders in Nigeria, including at the federal level and within the states of Kaduna and Kano, the metrics are then applied to a set of advocacy organizations within the country. We show that the metrics can provide insights into why some advocacy organizations are perceived as more effective than others by policymakers. Specifically, we find that geographical reach, the share of budget allocated to advocacy, action plans with clear objectives, large networks that include government and non-governmental policy champions, multiple media and dissemination outputs and numerous training events collectively increase nutrition advocates' visibility to, and influence on, policymakers. Although the metrics are subject to further testing in other country settings and need to be interpreted based on a country's underlying policy system, they offer a useful starting point for more systematic, comparative advocacy analysis and learning within the nutrition field and beyond.

Indexed as

Nutrition PolicyOrganizationsConsumer AdvocacyGovernmentHumansNigeriaNutritional StatusAdvocacyfood fortificationmetricsNigerianutritionpublic policy

Identifiers

PMID35482483
PMCPMC9469884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.